A Firmer Understanding Of Muscle Fibrosis In Duchenne Muscular Dystrophy

Main Category: Muscular Dystrophy / ALS
Also Included In: Bones / Orthopedics
Article Date: 03 Jan 2012 - 2:00 PST

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


Researchers describe how increased production of a microRNA promotes progressive muscle deterioration in a mouse model of Duchenne muscular dystrophy (DMD), according to a study published online on January 2 in the Journal of Cell Biology*.

As DMD patients age, their damaged muscle cells are gradually replaced by collagen-rich, fibrous tissue. This muscle fibrosis is partly induced by the growth factor TGF-beta, which is highly activated in DMD patients, though exactly how this cytokine promotes fibrogenesis is unclear. Pura Muñoz-Cánoves and colleagues examined the role of miR-21, a microRNA whose production is stimulated by TGF-beta signaling.

miR-21 was upregulated in the collagen-producing fibroblasts of both DMD patients and mice that develop disease symptoms similar to human muscular dystrophy (so-called mdx mice). Inhibiting miR-21 reduced collagen levels and prevented, or even reversed, fibrogenesis in diseased animals, whereas mdx mice overexpressing the microRNA produced more collagen and developed fibrotic muscles at earlier ages.

The researchers also discovered that TGF-beta activity and miR-21 production were regulated by the balance of two extracellular factors: uPA - a protease that activates TGF-beta - and its inhibitor PAI-1. mdx mice developed fibrotic muscles more quickly in the absence of PAI-1, but these symptoms could be reversed by inhibiting uPA with a drug or a specific siRNA. In addition to producing more collagen, PAI-1-null fibroblasts also proliferated rapidly because the extra miR-21 induced by active TGF-beta inhibited the tumor-suppressive phosphatase PTEN.

TGF-beta inhibitors prevent muscle fibrosis but have damaging side effects; this study suggests that uPA or miR-21 may make attractive alternative drug targets. Muñoz-Cánoves now wants to investigate the function of miR-21 in other cell types that influence muscle homeostasis, such as the macrophages involved in tissue repair.

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our muscular dystrophy / als section for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Rockefeller University Press. "A Firmer Understanding Of Muscle Fibrosis In Duchenne Muscular Dystrophy." Medical News Today. MediLexicon, Intl., 3 Jan. 2012. Web.
23 Feb. 2012. <http://www.medicalnewstoday.com/releases/239819.php>

APA
Rockefeller University Press. (2012, January 3). "A Firmer Understanding Of Muscle Fibrosis In Duchenne Muscular Dystrophy." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/239819.php.

Please note: If no author information is provided, the source is cited instead.


Muscular Dystrophy / ALS

Most Popular Articles



Follow Our Muscular Dystrophy News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Muscular Dystrophy / ALS Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »